Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 19/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 18/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 16/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.52 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7751548 | 0.97 | SLC6A4 (0.56) | SLC6A4SLC6A3SLC6A2CYP2D6CYP1A1 | |
| SCHEMBL7947168 | 0.95 | SLC6A2 (0.48) | SLC6A4SLC6A3SLC6A2CYP2D6CYP1A1 | |
| SCHEMBL7077339 | 0.94 | SLC6A4 (0.57) | SLC6A4SLC6A3SLC6A2CYP2D6CYP1A1 | |
| SCHEMBL8452305 | 0.91 | SLC6A4 (0.58) | SLC6A4SLC6A3SLC6A2CYP2D6CYP1A1 | |
| SCHEMBL6957304 | 0.89 | SLC6A2 (0.50) | SLC6A4SLC6A3SLC6A2CYP2D6CYP1A1 | |
| SCHEMBL6544366 | 0.85 | SLC6A3 (0.38) | SLC6A4SLC6A3SLC6A2CYP2D6 | |
| SCHEMBL8291781 | 0.84 | SLC6A3 (0.46) | SLC6A4SLC6A3SLC6A2CYP2D6CYP1A1 | |
| SCHEMBL7091052 | 0.84 | SLC6A4 (0.57) | SLC6A4SLC6A3SLC6A2CYP2D6CYP3A4 | |
| SCHEMBL7764201 | 0.84 | TACR1 (0.40) | SLC6A4SLC6A3SLC6A2CYP2D6 | |
| SCHEMBL7956526 | 0.82 | MEN1 (0.38) | SLC6A4SLC6A3SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0512901-B1 | Aminated polycyclic compounds and their enantiomers, process for their preparation and pharmaceutical compositions containing them | SANOFI SA (FR) | 1999-06-23 | — | — | EP | claimed |
| US-5770735-A | Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present | ELF SANOFI (FR) | 1998-06-23 | — | — | US | claimed |
| EP-0512901-B1 | Aminated polycyclic compounds and their enantiomers, process for their preparation and pharmaceutical compositions containing them | SANOFI SA (FR) | 1999-06-23 | — | — | EP | disclosed |
| US-5770735-A | Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions in which they are present | ELF SANOFI (FR) | 1998-06-23 | — | — | US | disclosed |
| US-5625060-A | Polycyclic amine compounds and their enantiomers, their method of preparation and pharmaceutical compositions on which they are present | Sanofi, Elf (FR) | 1997-04-29 | — | — | US | disclosed |
| US-5340822-A | Substance P, neurokinin antagonists | ELF SANOFI (FR) | 1994-08-23 | — | — | US | disclosed |
| EP-0512901-A1 | Aminated polycyclic compounds and their enantiomers, process for their preparation and pharmaceutical compositions containing them | SANOFI (FR) | 1992-11-11 | — | — | EP | disclosed |